On October 15, 2024, Cormorant Asset Management, LP (Trades, Portfolio) made a significant move in the biotechnology sector ...

Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday ...

Bright Minds Biosciences is working with Firefly Neuroscience, an AI healthcare company, to provide a full analysis of the electroencephalogram data in Bright Minds' Phase 2 clinical trial evaluating ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR ...

Bright Minds Biosciences shares are moving higher on Friday. The company announced a $35 million non-brokered private ...

Bright Minds Biosciences (NASDAQ: DRUG), a little-known biotech company, became the talk of the market yesterday after its ...

在近期的美股市场上，Bright Minds Biosciences（DRUG.US）以惊人的速度引起了投资者的关注。仅在五个交易日内，该公司的股价飙升了52倍，达到了历史新高。这一异动不仅令市场惊愕，也引发了各界对其背后原因的强烈探讨。那么，是什么驱动了这一股价的疯狂上涨？在这篇文章中，我们将深入分析Bright Minds Biosciences的近期动态、融资计划及其可能对市场带来的长期影响 ...

Shares of Bright Minds Biosciences on Friday shot higher after pricing a $35 million private placement. The stock was up 70% at $36.86 in pre-market trading. The company said it has priced the private ...

On Friday, Bright Minds Biosciences Inc (DRUG) stock saw a modest uptick, ending the day at $47.21 which represents a slight increase of $25.51 or 117.56% from the prior close of $21.7. The stock ...

波士顿——作为Bright Minds Biosciences Inc. (NASDAQ:DRUG)的重要股东，科莫兰特资产管理有限合伙公司(Cormorant Asset Management, LP)通过大规模收购普通股增加了其在该公司的持股。根据最近的SEC文件显示，科莫兰特及其附属公司在截至10月16日的两天内购买了总价值约320万美元的股份。 这些交易涉及多批普通股的购买，每股价格从4.

After two days of declines, shares of Bright Minds Biosciences (NASDAQ:DRUG) bounced back in the premarket on Friday with a ~48% rise after the psychedelic drug developer announced a private ...

18, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”) is pleased to announce a non-brokered private placement of common ...